Table 3.1 Characteristics of the included reviews Disease area Report Condition/ Quality GPBM/s Aims and objectives Number of reports population included (number of studies)* Autoimmune Castelino Systemic lupus Poor EQ-5D To evaluate the development and 13 (13) system (2013) erythematosus psychometric properties of SF-6D health related quality of life measures used in adults with systemic lupus erythematosus Holloway Systemic lupus Poor EQ-5D To create a conceptual model of 68 (68) (2014) erythematosus the humanistic and economic burden of systemic lupus erythematosus and review the patient reported outcomes used to measure the concept in SLE clinical trials Cardiovascular Dyer (2010) Heart disease Good EQ-5D To synthetize the evidence on 66 (66) system the validity and reliability of the SF-6D EQ-5D in studies within the cardiovascular field; to HUI 3 summarize the EQ-5D based score reported in studies within the cardiovascular field; and to attempt to stratify mean utility
Table 3.1 Characteristics of the included reviews Disease area Report Condition/ population Quality GPBM/s included Aims and objectives Number of reports (number of studies)* Autoimmune system Castelino (2013) Systemic lupus erythematosus Poor EQ-5D SF-6D To evaluate the development and psychometric properties of health related quality of life measures used in adults with systemic lupus erythematosus 13 (13) Holloway (2014) Systemic lupus erythematosus Poor EQ-5D To create a conceptual model of the humanistic and economic burden of systemic lupus erythematosus and review the patient reported outcomes used to measure the concept in SLE clinical trials 68 (68) Cardiovascular system Dyer (2010) Heart disease Good EQ-5D SF-6D HUI 3 To synthetize the evidence on the validity and reliability of the EQ-5D in studies within the cardiovascular field; to summarize the EQ-5D based score reported in studies within the cardiovascular field; and to attempt to stratify mean utility 66 (66)